Maldives receives 5,000 doses of Chinese Sinopharm vaccine

Sinopharm vaccine | Photo: Beijing Daily

Male’, Maldives – Health Emergency Operations Center (HEOC) has announced that Maldives has received 5,000 doses of the Covid-19 vaccine, Sinopharm developed by China.

HEOC spokesperson Dr. Nazla Rafeeq said that the 5,000 vaccines were currently stored and would be permitted by the Food and Drug Authority of the Maldives after assessments.

Sinopharm is widely used in China and was developed by two companies from the nation. Sinovac and Sinopharm are the two vaccines predominantly used in China. The two vaccines have about 78 percent effectiveness against COVID-19.

The Maldives commenced vaccinations yesterday. Currently, the Covishield vaccine developed by Astrazeneca-Oxford University is used in the Maldives. The vaccine is manufactured by the Serum Institute of India.

The first batch was 100,000 doses gifted by India to the Maldives. More vaccine doses are to be received through the WHO COVAX facility, that will arrive mid February. A further 700,000 doses of the vaccine are being procured by the Maldivian government, expected to be received in March. The Health Minister recently announced that Maldives will also procure the Pfizer-BioNtech vaccineBeijing Daily.